Literature DB >> 18287229

Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.

Arban Domi1, Andrea S Weisberg, Bernard Moss.   

Abstract

The vaccinia virus E2L (VACWR058) gene is conserved in all sequenced chordopoxviruses and is predicted to encode an 86-kDa protein with no recognizable functional motifs or nonpoxvirus homologs. Although the region immediately upstream of the open reading frame lacked optimal consensus promoter motifs, expression of the E2 protein occurred after viral DNA replication. Transfection studies, however, indicated that the promoter was weak compared to well-characterized intermediate and late promoters. The E2 protein was present in mature virions purified from infected cells but was more abundant in extracellular enveloped forms. Despite the conservation of the E2L gene in chordopoxviruses, deletion mutants could be isolated from both the WR and IHD-J strains of vaccinia virus. These null mutants produced very small plaques in all cell lines tested, reduced amounts of mature infectious virions, and very low numbers of extracellular virions. Nevertheless, viral protein synthesis appeared qualitatively and quantitatively normal. The defect in extracellular virus formation was corroborated by electron microscopy, which also showed some aberration in the wrapping of virions by cisternal membranes. Extracellular virions that did form, however, were able to induce actin tail formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287229      PMCID: PMC2293024          DOI: 10.1128/JVI.00037-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.

Authors:  T Betakova; E J Wolffe; B Moss
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Late budding domains and host proteins in enveloped virus release.

Authors:  Paul D Bieniasz
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

3.  Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.

Authors:  Suany Ojeda; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  In a nutshell: structure and assembly of the vaccinia virion.

Authors:  Richard C Condit; Nissin Moussatche; Paula Traktman
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

5.  Protein composition of the vaccinia virus mature virion.

Authors:  Wolfgang Resch; Kim K Hixson; Ronald J Moore; Mary S Lipton; Bernard Moss
Journal:  Virology       Date:  2006-09-26       Impact factor: 3.616

6.  Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Authors:  Bruce A Knutson; Xu Liu; Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation.

Authors:  S Röttger; F Frischknecht; I Reckmann; G L Smith; M Way
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.

Authors:  Che-Sheng Chung; Chein-Hung Chen; Ming-Yi Ho; Cheng-Yen Huang; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.

Authors:  Jennifer D Yoder; Tsefang S Chen; Cliff R Gagnier; Srilakshmi Vemulapalli; Claudia S Maier; Dennis E Hruby
Journal:  Virol J       Date:  2006-03-01       Impact factor: 4.099

10.  Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein.

Authors:  Esteban Herrero-Martínez; Kim L Roberts; Michael Hollinshead; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-11       Impact factor: 3.891

View more
  20 in total

1.  Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Aistė Tamošiūnaitė; Robert Klopfleisch; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 2.  Coupling viruses to dynein and kinesin-1.

Authors:  Mark P Dodding; Michael Way
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

3.  The Ectodomain of the Vaccinia Virus Glycoprotein A34 Is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with Glycoprotein B5.

Authors:  Stephanie R Monticelli; Amalia K Earley; Jessica Tate; Brian M Ward
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

4.  Generation of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

5.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

6.  Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.

Authors:  Peter Bryk; Matthew G Brewer; Brian M Ward
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Vaccinia virus A43R gene encodes an orthopoxvirus-specific late non-virion type-1 membrane protein that is dispensable for replication but enhances intradermal lesion formation.

Authors:  Cindy L Sood; Bernard Moss
Journal:  Virology       Date:  2009-11-08       Impact factor: 3.616

8.  Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export.

Authors:  Gareth W Morgan; Michael Hollinshead; Brian J Ferguson; Brendan J Murphy; David C J Carpentier; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

9.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  Interaction of poxvirus intracellular mature virion proteins with the TPR domain of kinesin light chain in live infected cells revealed by two-photon-induced fluorescence resonance energy transfer fluorescence lifetime imaging microscopy.

Authors:  Ananya Jeshtadi; Pierre Burgos; Christopher D Stubbs; Anthony W Parker; Linda A King; Michael A Skinner; Stanley W Botchway
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.